Concourse Financial Group Securities, Inc. Cytosorbents Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.7 - $1.55 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.7 - $1.01 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.86 - $1.07 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.08 - $1.94 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.86 - $4.03 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.86 - $4.03 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$2.37 - $3.65 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.79 - $4.17 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.03 - $2.03 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.2 - $2.46 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.76 - $3.22 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.88 - $4.23 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.05 - $8.11 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$7.0 - $9.71 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$7.55 - $9.42 $0 - $0
Q1 2021 May 13, 2021	BUY	$8.23 - $11.48 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$7.65 - $8.98 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $0 - $0
Q1 2020 May 13, 2020	BUY	$3.77 - $7.73 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.33 - $7.63 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$5.92 - $7.78 $0 - $0
Q1 2019 May 15, 2019	BUY	$6.82 - $8.56 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $0 - $0

Others Institutions Holding CTSO

# of Institutions

Shares Held

16.7M

Call Options Held

15.4K

Put Options Held

Avenir Corp Washington, DC

2.98M
Shares

$2.83 Million
0.45% of portfolio
Skylands Capital, LLC

2.76M
Shares

$2.62 Million
0.6% of portfolio
Granahan Investment Management, LLC Waltham, MA

2.09M
Shares

$1.99 Million
0.13% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$1.85 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.78M
Shares

$1.69 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $41.4M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account